State News
-
UTAH LEADS TOGETHER – STATE COVID-19 BRIDGE LOANS GO LIVE
On Tuesday, March 31, the Utah Leads Together Bridge Loan Program led by the Governor’s Office of Economic…
-
Salt Lake Chamber: CARES Act
Dear Chamber Member, The Utah Economic Response Task Force is committed to maximizing the number of Utah businesses…
-
SLCo Issues Public Health Order: “Salt Lake County: Stay Safe. Stay Home.”
Press release from the Salt Lake County Health Department: Mandatory order emphasizes the importance of staying safe at…
-
GOED & the State of Utah Announce Loan Program for Small Businesses
The Governor’s Office of Economic Development on behalf of the State of Utah has announced the implementation of…
-
Governor Herbert Releases Economic Response Plan
On Tuesday, March 24, 2020, Governor Herbert unveiled the state economic response plan entitled, “Utah Leads Together”. The…
-
BioUtah’s Summary of Governor’s Economic Response Plan
On Tuesday afternoon, March 24, 2020, Governor Herbert unveiled an economic response plan to the coronavirus CoronaVirus for…
-
BioUtah COVID-19 Life Sciences Survey
TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
